Anavex Life Sciences Corp (AVXL)
12.46
-0.10
(-0.76%)
USD |
NASDAQ |
Dec 27, 10:12
Anavex Life Sciences Research and Development Expense (Quarterly): 11.56M for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Avid Bioservices Inc | -- |
| Alaunos Therapeutics Inc | 0.143M |
| SELLAS Life Sciences Group Inc | 4.362M |
| Galectin Therapeutics Inc | 7.595M |
| Oragenics Inc | 0.879M |